Deep-Track-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
69
Total Value
3088173822
Accession Number
0001856083-25-000002
Form Type
13F-HR
Manager Name
Deep-Track-Capital-Lp
Data Enrichment
93% identified
64 identified5 unidentified

Holdings

69 positions • $3.1B total value
Manager:
Search and click to pin securities to the top
Page 3 of 4
Sage Therapeutics, Inc.
Shares:2.0M
Value:$16.2M
% of Portfolio:0.5% ($16.2M/$3.1B)
Terns Pharmaceuticals, Inc.
Shares:5.6M
Value:$15.4M
% of Portfolio:0.5% ($15.4M/$3.1B)
Korro Bio, Inc.
Shares:874.6K
Value:$15.2M
% of Portfolio:0.5% ($15.2M/$3.1B)
Oruka Therapeutics, Inc.
Shares:1.4M
Value:$14.8M
% of Portfolio:0.5% ($14.8M/$3.1B)
Mind Medicine (MindMed) Inc.
Shares:2.5M
Value:$14.6M
% of Portfolio:0.5% ($14.6M/$3.1B)
Upstream Bio, Inc.
Shares:2.3M
Value:$14.1M
% of Portfolio:0.5% ($14.1M/$3.1B)
Olema Pharmaceuticals, Inc.
Shares:3.4M
Value:$12.9M
% of Portfolio:0.4% ($12.9M/$3.1B)
Septerna, Inc.
Shares:1.9M
Value:$11.1M
% of Portfolio:0.4% ($11.1M/$3.1B)
NOVAVAX INC
Shares:1.5M
Value:$9.7M
% of Portfolio:0.3% ($9.7M/$3.1B)
CYBIN INC.
Shares:1.5M
Value:$9.7M
% of Portfolio:0.3% ($9.7M/$3.1B)
RAPT Therapeutics, Inc.
Shares:6.0M
Value:$7.3M
% of Portfolio:0.2% ($7.3M/$3.1B)
PLIANT THERAPEUTICS, INC.
Shares:5.4M
Value:$7.3M
% of Portfolio:0.2% ($7.3M/$3.1B)
Avalo Therapeutics, Inc.
Shares:859.9K
Value:$6.9M
% of Portfolio:0.2% ($6.9M/$3.1B)
BICYCLE THERAPEUTICS PLC
Shares:767.0K
Value:$6.5M
% of Portfolio:0.2% ($6.5M/$3.1B)
Beam Therapeutics Inc.
Shares:315.8K
Value:$6.2M
% of Portfolio:0.2% ($6.2M/$3.1B)
Invivyd, Inc.
Shares:9.7M
Value:$5.9M
% of Portfolio:0.2% ($5.9M/$3.1B)
Xencor Inc
Shares:549.4K
Value:$5.8M
% of Portfolio:0.2% ($5.8M/$3.1B)
Regulus Therapeutics Inc.
Shares:3.3M
Value:$5.7M
% of Portfolio:0.2% ($5.7M/$3.1B)
INOVIO PHARMACEUTICALS, INC.
Shares:3.1M
Value:$5.1M
% of Portfolio:0.2% ($5.1M/$3.1B)
Rapport Therapeutics, Inc.
Shares:457.6K
Value:$4.6M
% of Portfolio:0.1% ($4.6M/$3.1B)